Freshfields and Wachtell steer AstraZeneca/Alexion
Shutterstock/Ascannio
AstraZeneca has tapped Freshfields Bruckhaus Deringer to guide its $39 billion acquisition of Alexion Pharmaceuticals, which is being advised by Wachtell Lipton Rosen & Katz.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10